| Serological tests play an important role in the surveillance and management of epidemics or pandemics, as well as in acquired immunity studies. Currently, COVID-19 serology is performed by well-established immunoassay techniques, which provide high sensitivities, but require specialized laboratories with trained personnel and processing times of 3 to 48 hours. | |
| A much faster and easier method is the lateral flow assay— such as the rapid diagnostic tests sold in pharmacies. However, the latter are not fully reliable, as they exhibit only moderate sensitivity and specificity. | |
| A team of researchers led by Prof. Laura M. Lechuga, CSIC Research Professor and head of the NanoBiosensors and Bioanalytical Applications Group at the Catalan Institute of Nanoscience and Nanotechnology (ICN2), has developed and extensively validated a novel serological nano-biosensor that provides a rapid (less than 15 minutes) identification and quantification of SARS-COV-2 antibodies in blood serum, without the need for sample pre-treatment and lengthy processing. It employs an optical sensing device based on a plasmonic technique that Prof. Lechuga’s group has been consolidating for years and has implemented for the diagnostics of diverse diseases and conditions –such as detection of cancer biomarkers, gluten ingestion or antibiotic allergy. |
| Extensive testing on clinical samples, provided by the Vall d’Hebron University Hospital and the Hospital Clínic of Barcelona–IDIBAPS during the first months of COVID-19 pandemic, was performed to prove the efficacy and reliability of this biosensor technology. In particular, 120 samples of serum were used, of which 100 from confirmed COVID-19 positive patients and 20 negative ones (collected prior to the outbreak of the pandemic). Comparative analyses with standard techniques and commercial lateral flow assays showed that this plasmonic biosensor technology outperforms well-established diagnostic methods, providing excellent sensitivity (99%) and specificity (100%). | |
| Such remarkable accuracy and the short operation times (the result is available in less than 15 minutes) make of this new biosensor an outstanding tool for rapid and reliable serological tests. Fast and quantitative serology is crucial for monitoring the evolution of the COVID-19 pandemic, managing patients’ hospitalization and placement in intensive care units and assessing the immunological status of individuals during vaccination campaigns and in the presence of emerging variants of the virus. | |
| Since the read-out device is compact and the procedure can be automatized, this technology has also potential for point-of-care applications and could be introduced in doctors’ practices and pharmacies. In addition, the same technique can be employed for the detection of various substances in body fluids –such as gluten peptides, early cancer biomarkers, anticoagulant drugs, or antibiotic allergy antibodies — thus, for the diagnostics and monitoring of many diseases. | |
| The readiness level of this technique is already very high and their developers are committed to achieve a fast technology transfer to industry, in order to introduce this new biosensor device both in the clinical environment and in decentralised settings. Watch this animation illustrating how a portable read-out device with disposal cartridges would work. | |
| The results of this study, carried out in the framework of the EU funded project CoNVaT, have been published in Analytical Chemistry (“Label-Free Plasmonic Biosensor for Rapid, Quantitative, and Highly Sensitive COVID-19 Serology: Implementation and Clinical Validation”). The research has been developed by Prof Lechuga’s group in collaboration with the Intensive Care and Clinical Microbiology Departments of the Vall d’Hebron University Hospital (Barcelona, Spain), the Department of Pneumology of the Hospital Clínic of Barcelona-IDIBAPS, and the Emerging Virus Unit of Aix-Marseille University (France). Senior researchers Dr Maria Soler and Dr M. Carmen Estévez are the corresponding authors, while PhD student Olalla Calvo-Lozano is the first author, having performed the optimization and validation of the system. |
News
Half of vaccines are binned – ‘fridge-free’ versions could change that
Vaccines that do not need to be kept cool in a fridge have been successfully trialed in patients for the first time, say UK scientists. Currently, most vaccines need to be refrigerated or frozen [...]
Mushroom Mystery: The Fungus That Makes People See Tiny Humans
A mushroom sold in markets and served in restaurants in Southwest China has an unusual warning attached to it: cook it thoroughly, or you may start seeing tiny people. For decades, people have reported [...]
Artificial intelligence used to design brand new viruses
Artificial Intelligence has been used to design brand new viruses that are fully functional and can replicate in the laboratory, say US researchers. It is the first time whole genomes have been successfully designed [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
Moderna kicks off Phase I Ebola trial as Africa readies itself for research
If the Phase I trial is successful, Moderna plans to quickly initiate Phase II and Phase III trials of its Ebola vaccine. Moderna has initiated a Phase I trial of its mRNA Ebola vaccine [...]
3D Human Brain Tissue Model Replicates Alzheimer’s Pathology
Summary: Researchers introduced a highly reproducible three-dimensional human brain tissue model capable of replicating complex neurodegenerative processes in Alzheimer’s disease. Developed over nine years using human stem cells, the self-organizing tissue spheroids integrate functional neurons, [...]
A Common Sugar May Loosen Cancer Cells and Help Them Spread
Chemotherapy may kill most ovarian cancer cells, but the few that survive can turn dangerously active. By releasing fructose, they may help nearby tumor cells break free and spread. Researchers at The Wistar Institute [...]
COVID-19 can wake up dormant viruses in the body, large study confirms
Virus reactivations by SARS-CoV-2 could worsen initial symptoms and increase risk of Long Covid. Early in the COVID-19 pandemic, scientists noticed that a SARS-CoV-2 infection can “wake up” other, dormant viruses already present in [...]
Scientists Discover the Brain May Enter a New Biological Phase Between 50 and 75
A single-cell study reveals major changes in immune cells, genome organization, and gene regulation within the aging human hippocampus, offering important insights into brain aging and dementias associated with age. Between roughly ages 50 [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Unzipping the Code of Life: Scientists Pinpoint Where DNA First Opens
Researchers mapped where DNA first opens and how a helicase gate may release one strand as genome copying begins. Before a cell can divide, it must open its tightly wound DNA and begin copying the entire [...]
Scientists Tested an 8-Hour Eating Window and Found a Surprising Brain Benefit
Limiting the daily eating window may provide brain benefits beyond those associated with weight loss. Eating within a shorter daily window may provide cognitive benefits beyond those associated with weight loss alone, according to [...]
Focused Ultrasound Opens Blood-Brain Barrier to Treat Brain Cancer
Summary: A new study demonstrates that primary brain tumors (gliomas) are particularly receptive to targeted drug delivery using focused ultrasound (FUS) combined with microbubbles. The team developed a high-resolution MRI protocol to track blood-brain barrier [...]
AI’s promise and practical limits in drug discovery
AI tools are becoming increasingly common in early drug discovery, allowing scientists to analyse data and navigate large volumes of research. However, according to Dr Raminderpal Singh, turning that potential into consistent scientific workflows [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Healthcare Headlines: Challenges and Advances in 2026
Health-related updates reveal financial adjustments by Universal Health Services due to Medicaid reimbursement uncertainties, significant pollution-linked health concerns from French-British oil firm Perenco in Congo, drug trial setbacks, potential restructuring at major medical firms, [...]
